149 related articles for article (PubMed ID: 11820306)
1. Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations.
Aras S; Yilmaz G; Alpas I; Baltaci V; Tayanç E; Aydin P
Eur J Ophthalmol; 2001; 11(4):351-5. PubMed ID: 11820306
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.
Kalayci D; Gürgey A; Güven D; Parlak H; Hasiripi H
Acta Ophthalmol Scand; 1999 Dec; 77(6):622-4. PubMed ID: 10634550
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease.
Batioğlu F; Atmaca LS; Karabulut HG; Beyza Sayin D
Acta Ophthalmol Scand; 2003 Jun; 81(3):283-5. PubMed ID: 12780409
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic mutations and risk of retinal vein occlusion.
Biancardi AL; Gadelha T; Borges WI; Vieira de Moraes H; Spector N
Arq Bras Oftalmol; 2007; 70(6):971-4. PubMed ID: 18235909
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
8. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of factor V Leiden in patients with retinal vein occlusion.
Demirci FY; Güney DB; Akarçay K; Kir N; Ozbek U; Sirma S; Unaltuna N; Ongör E
Acta Ophthalmol Scand; 1999 Dec; 77(6):631-3. PubMed ID: 10634553
[TBL] [Abstract][Full Text] [Related]
10. Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation.
Incorvaia C; Bandello F; Parmeggiani F; D'Angelo S; Costagliola C; Sebastiani A
Eur J Ophthalmol; 2002; 12(2):131-4. PubMed ID: 12022286
[TBL] [Abstract][Full Text] [Related]
11. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden, activated protein C resistance, and retinal vein occlusion.
Ciardella AP; Yannuzzi LA; Freund KB; DiMichele D; Nejat M; De Rosa JT; Daly JR; Sisco L
Retina; 1998; 18(4):308-15. PubMed ID: 9730172
[TBL] [Abstract][Full Text] [Related]
13. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
Koylu MT; Kucukevcilioglu M; Erdurman FC; Durukan AH; Sobacı G; Torun D; Tunca Y; Ayyildiz O
Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype.
Incorvaia C; Lamberti G; Parmeggiani F; Ferraresi P; Calzolari E; Bernardi F; Sebastiani A
Am J Ophthalmol; 1999 Aug; 128(2):247-8. PubMed ID: 10458191
[TBL] [Abstract][Full Text] [Related]
15. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
Huber S; McMaster KJ; Voelkerding KV
J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
17. [Central retinal vein occlusion in a factor V leiden and G21210A prothrombin variant carrier].
Suárez Baraza J; Calzado Hinojosa J; Caracena Ordóñez JM; Miralles de Imperial J
Arch Soc Esp Oftalmol; 2004 Sep; 79(9):457-60. PubMed ID: 15389368
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
19. Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
Hvarfner C; Hillarp A; Larsson J
Br J Ophthalmol; 2003 Mar; 87(3):305-6. PubMed ID: 12598443
[TBL] [Abstract][Full Text] [Related]
20. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
